197 related articles for article (PubMed ID: 16959142)
1. Comparison of urine and oral fluid as matrices for screening of thirty-three benzodiazepines and benzodiazepine-like substances using immunoassay and LC-MS(-MS).
Smink BE; Mathijssen MP; Lusthof KJ; de Gier JJ; Egberts AC; Uges DR
J Anal Toxicol; 2006 Sep; 30(7):478-85. PubMed ID: 16959142
[TBL] [Abstract][Full Text] [Related]
2. Comparison of immunoassay screening tests and LC-MS-MS for urine detection of benzodiazepines and their metabolites: results of a national proficiency test.
Bertol E; Vaiano F; Borsotti M; Quercioli M; Mari F
J Anal Toxicol; 2013; 37(9):659-64. PubMed ID: 23943436
[TBL] [Abstract][Full Text] [Related]
3. Limitations of EMIT benzodiazepine immunoassay for monitoring compliance of patients with benzodiazepine therapy even after hydrolyzing glucuronide metabolites in urine to increase cross-reactivity: comparison of immunoassay results with LC-MS/MS values.
Dixon RB; Floyd D; Dasgupta A
Ther Drug Monit; 2015 Feb; 37(1):137-9. PubMed ID: 25004136
[TBL] [Abstract][Full Text] [Related]
4. Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays.
Pettersson Bergstrand M; Helander A; Hansson T; Beck O
Drug Test Anal; 2017 Apr; 9(4):640-645. PubMed ID: 27366870
[TBL] [Abstract][Full Text] [Related]
5. Oral fluid is a viable alternative for monitoring drug abuse: detection of drugs in oral fluid by liquid chromatography-tandem mass spectrometry and comparison to the results from urine samples from patients treated with Methadone or Buprenorphine.
Vindenes V; Yttredal B; Oiestad EL; Waal H; Bernard JP; Mørland JG; Christophersen AS
J Anal Toxicol; 2011 Jan; 35(1):32-9. PubMed ID: 21219701
[TBL] [Abstract][Full Text] [Related]
6. Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers.
Vindenes V; Lund HM; Andresen W; Gjerde H; Ikdahl SE; Christophersen AS; Øiestad EL
Forensic Sci Int; 2012 Jun; 219(1-3):165-71. PubMed ID: 22284072
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous analysis of 14 benzodiazepines in oral fluid by solid-phase extraction and LC-MS-MS.
Ngwa G; Fritch D; Blum K; Newland G
J Anal Toxicol; 2007 Sep; 31(7):369-76. PubMed ID: 17725884
[TBL] [Abstract][Full Text] [Related]
8. The online screening technique for urinary benzodiazepines: comparison with EMIT, FPIA, and GC-MS.
Beck O; Lin Z; Brodin K; Borg S; Hjemdahl P
J Anal Toxicol; 1997; 21(7):554-7. PubMed ID: 9399125
[TBL] [Abstract][Full Text] [Related]
9. Measurement of benzodiazepines in urine by liquid chromatography-tandem mass spectrometry: confirmation of samples screened by immunoassay.
Glover SJ; Allen KR
Ann Clin Biochem; 2010 Mar; 47(Pt 2):111-7. PubMed ID: 19969595
[TBL] [Abstract][Full Text] [Related]
10. Replacement of immunoassay by LC tandem mass spectrometry for the routine measurement of drugs of abuse in oral fluid.
Allen KR; Azad R; Field HP; Blake DK
Ann Clin Biochem; 2005 Jul; 42(Pt 4):277-84. PubMed ID: 15989728
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic performance of Triage for benzodiazepines: urine analysis of the dose of therapeutic cases.
Kurisaki E; Hayashida M; Nihira M; Ohno Y; Mashiko H; Okano T; Niwa S; Hiraiwa K
J Anal Toxicol; 2005 Sep; 29(6):539-43. PubMed ID: 16168176
[TBL] [Abstract][Full Text] [Related]
12. KIMS, CEDIA, and HS-CEDIA immunoassays are inadequately sensitive for detection of benzodiazepines in urine from patients treated for chronic pain.
Darragh A; Snyder ML; Ptolemy AS; Melanson S
Pain Physician; 2014; 17(4):359-66. PubMed ID: 25054395
[TBL] [Abstract][Full Text] [Related]
13. Urine benzodiazepine screening using Roche Online KIMS immunoassay with beta-glucuronidase hydrolysis and confirmation by gas chromatography- mass spectrometry.
Klette KL; Wiegand RF; Horn CK; Stout PR; Magluilo J
J Anal Toxicol; 2005 Apr; 29(3):193-200. PubMed ID: 15842763
[TBL] [Abstract][Full Text] [Related]
14. Urine Drug Screening in the Era of Designer Benzodiazepines: Comparison of Three Immunoassay Platforms, LC-QTOF-MS and LC-MS-MS.
Puzyrenko A; Wang D; Schneider R; Wallace G; Schreiber S; Brandt K; Gunsolus IL
J Anal Toxicol; 2022 Aug; 46(7):712-718. PubMed ID: 34557900
[TBL] [Abstract][Full Text] [Related]
15. Comparison between drug screening by immunoassay and ultra-high performance liquid chromatography/high-resolution time-of-flight mass spectrometry in post-mortem urine.
Sundström M; Pelander A; Ojanperä I
Drug Test Anal; 2015 May; 7(5):420-7. PubMed ID: 24953563
[TBL] [Abstract][Full Text] [Related]
16. Oxaprozin cross-reactivity in three commercial immunoassays for benzodiazepines in urine.
Fraser AD; Howell P
J Anal Toxicol; 1998; 22(1):50-4. PubMed ID: 9491969
[TBL] [Abstract][Full Text] [Related]
17. Screening and confirmatory method for benzodiazepines and hypnotics in oral fluid by LC-MS/MS.
Kintz P; Villain M; Concheiro M; Cirimele V
Forensic Sci Int; 2005 Jun; 150(2-3):213-20. PubMed ID: 15944062
[TBL] [Abstract][Full Text] [Related]
18. Comparison of drugs of abuse detection in meconium by EMIT II and ELISA.
Marin SJ; Keith L; Merrell M; McMillin GA
J Anal Toxicol; 2009 Apr; 33(3):148-54. PubMed ID: 19371463
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of the accuracy of benzodiazepine testing in chronic pain patients utilizing immunoassay with liquid chromatography tandem mass spectrometry (LC/MS/MS) of urine drug testing.
Manchikanti L; Malla Y; Wargo BW; Fellows B
Pain Physician; 2011; 14(3):259-70. PubMed ID: 21587329
[TBL] [Abstract][Full Text] [Related]
20. Detection of 4 benzodiazepines in oral fluid as biomarker for presence in blood.
Gjerde H; Langel K; Favretto D; Verstraete AG
Ther Drug Monit; 2014 Apr; 36(2):252-6. PubMed ID: 24061449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
